Thanks, Mike. You may not like to know the following info because it means that this work has hit road blocks before, due to egos, funding and the FDA.

The first one is the Drachman study. This work rides on the shoulders of the targeted chemotherapy research done in the past several years. Alice could tell you about that.

http://www.ncbi.nlm.nih.gov/pubmed/22769060

And I'm sure a lot of you are familiar with the work of Dr. Blalock in regards to attempting to get a vaccine for MG. There's been a "block" of his work, I believe due to the fact that the big guys (like JH and MC) wanted to come up with something better so they could get the credit.

http://www.ncbi.nlm.nih.gov/pubmed/21861992

Here's some history on that.

http://www.uab.edu/medicine/neurobio...ty/66-eblalock

http://online.wsj.com/article/SB1000...342139200.html

These are relatively related.

http://www.ncbi.nlm.nih.gov/pubmed/22981737

http://www.ncbi.nlm.nih.gov/pubmed/22941261

http://www.ncbi.nlm.nih.gov/pubmed/22952904

http://www.ncbi.nlm.nih.gov/pubmed/22689047

http://www.ncbi.nlm.nih.gov/pubmed/22642809

http://www.ncbi.nlm.nih.gov/pubmed/22626443

And this is for you MuSK patients.

http://www.ncbi.nlm.nih.gov/pubmed/22396395

And what they're working on to help determine severity of MG. As if we can't figure that out without a study!

http://www.ncbi.nlm.nih.gov/pubmed/21861992